whether aggressive blood-glucose lowering is HARMFUL in some type 2 diabetes patients

Experts are now debating whether aggressive blood-glucose lowering is HARMFUL in some type 2 diabetes patients.

This comes from early results of the big "ACCORD" trial.

It was expected to show that intensive control of glucose, lipids, or blood pressure would IMPROVE outcomes in type 2 diabetes patients at high cardiovascular risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote